891
Views
0
CrossRef citations to date
0
Altmetric
HPV

The influence of political ideology on awareness of HPV and HPV vaccine among adults in the United States

ORCID Icon, , & ORCID Icon
Article: 2232706 | Received 30 Mar 2023, Accepted 30 Jun 2023, Published online: 02 Aug 2023

References

  • Centers for Disease Control and Prevention. Cancers associated with human papillomavirus, United States—2015–2019. USCS Data Brief, no 32. Atlanta (GA): Centers for Disease Control and Prevention, US Department of Health and Human Services; 2022.
  • Chido-Amajuoyi OG, Talluri R, Wonodi C, Shete S. Trends in HPV vaccination initiation and completion within ages 9–12 years: 2008–2018. Pediatrics. 2021;147(6). doi:10.1542/peds.2020-012765.
  • Chido-Amajuoyi OG, Jackson I, Yu R, Shete S. Declining awareness of HPV and HPV vaccine within the general US population. Human Vaccines Immunother. 2020;17:420–7. doi:10.1080/21645515.2020.1783952.
  • Navarro V, Muntaner C, Borrell C, Benach J, Quiroga Á, Rodríguez-Sanz M, Vergés N, Pasarín MI. Politics and health outcomes. Lancet. 2006;368(9540):1033–7. doi:10.1016/S0140-6736(06)69341-0.
  • Neelon B, Mutiso F, Mueller NT, Pearce JL, Benjamin-Neelon SE. Associations between governor political affiliation and COVID-19 cases, deaths, and testing in the US. Am J Prev Med. 2021;61(1):115–19. doi:10.1016/j.amepre.2021.01.034.
  • Shete SS, Yu R, Shete S. Political ideology and the support or opposition to United States tobacco control policies. JAMA Netw Open. 2021;4(9):e2125385. doi:10.1001/jamanetworkopen.2021.25385.
  • Baumgaertner B, Carlisle JE, Justwan F, Rabinowitz M. The influence of political ideology and trust on willingness to vaccinate. PLoS One. 2018;13(1):e0191728. doi:10.1371/journal.pone.0191728.
  • Manganello JA, Chiang SC, Cowlin H, Kearney MD, Massey PM. HPV and COVID-19 vaccines: social media use, confidence, and intentions among parents living in different community types in the United States. J Behav Med. 2023;46(1–2):212–28. doi:10.1007/s10865-022-00316-3.
  • Gollust SE, Attanasio L, Dempsey A, Benson AM, Fowler EF. Political and news media factors shaping public awareness of the HPV vaccine. Womens Health Issues. 2013;23(3):e143–e51. doi:10.1016/j.whi.2013.02.001.
  • Gerend MA, Shepherd JE. Correlates of HPV knowledge in the era of HPV vaccination: a study of unvaccinated young adult women. Women Health. 2011;51(1):25–40. doi:10.1080/03630242.2011.540744.
  • Chido-Amajuoyi OG, Pande M, Agbajogu C, Yu RK, Cunningham S, Shete S. HPV vaccination uptake, hesitancy, and refusal: observations of health-care professionals during the COVID-19 pandemic. JNCI Cancer Spectr. 2022;6(4):kac053. doi:10.1093/jncics/pkac053.
  • Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245–51. doi:10.1016/j.puhe.2021.02.025.
  • Gollust SE, LoRusso SM, Nagler RH, Fowler EF. Understanding the role of the news media in HPV vaccine uptake in the United States: synthesis and commentary. Hum Vaccin Immunother. 2016;12(6):1430–4. doi:10.1080/21645515.2015.1109169.
  • Daley EM, Vamos CA, Thompson EL, Zimet GD, Rosberger Z, Merrell L, Kline NS. The feminization of HPV: how science, politics, economics and gender norms shaped U.S. HPV vaccine implementation. Papillomavirus Res. 2017;3:142–8. doi:10.1016/j.pvr.2017.04.004.
  • Udesky L. Push to mandate HPV vaccine triggers backlash in USA. Lancet. 2007;369(9566):979–80. doi:10.1016/S0140-6736(07)60475-9.
  • Franco M, Mazzucca S, Padek M, Brownson RC. Going beyond the individual: how state-level characteristics relate to HPV vaccine rates in the United States. BMC Public Health. 2019;19(1):1–9. doi:10.1186/s12889-019-6566-y.
  • Bernstein S, North A, Schwartz J, Niccolai LM. State-level voting patterns and adolescent vaccination coverage in the United States, 2014. Am J Public Health. 2016;106(10):1879–81. doi:10.2105/AJPH.2016.303381.
  • Amboree TL, Montealegre JR, Wermuth PP, Mgbere O, Fujimoto K, Darkoh C. Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population. Prev Med Rep. 2022;28:101853. doi:10.1016/j.pmedr.2022.101853.
  • Pink SL, Chu J, Druckman JN, Rand DG, Willer R. Elite party cues increase vaccination intentions among republicans. Proc Natl Acad Sci USA. 2021;118(32):e2106559118. doi:10.1073/pnas.2106559118.
  • Ward JK, Alleaume C, Peretti-Watel P, Peretti-Watel P, Seror V, Cortaredona S, Launay O, Raude J, Verger P, Beck F, et al. The French public’s attitudes to a future COVID-19 vaccine: the politicization of a public health issue. Social Sci Med. 2020;265:113414. doi:10.1016/j.socscimed.2020.113414.
  • Wollebæk D, Fladmoe A, Steen‐Johnsen K, Ihlen Ø. Right‐wing ideological constraint and vaccine refusal: the case of the COVID‐19 vaccine in Norway. Scand Pol Stud. 2022;45(2):253–78. doi:10.1111/1467-9477.12224.
  • Smith DT, Attwell K, Evers U. Support for a COVID-19 vaccine mandate in the face of safety concerns and political affiliations: an Australian study. Politics. 2022;42(4):480–91. doi:10.1177/02633957211009066.
  • Abiola SE, Colgrove J, Mello MM. The politics of HPV vaccination policy formation in the United States. J Health Polit Policy Law. 2013;38(4):645–81. doi:10.1215/03616878-2208567.
  • Bednarczyk RA. Addressing HPV vaccine myths: practical information for healthcare providers. Hum Vaccin Immunother. 2019;15(7–8):1628–38. doi:10.1080/21645515.2019.1565267.
  • Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW. Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation. Prev Med. 2013;57(5):414–8. doi:10.1016/j.ypmed.2013.05.013.
  • Hersh ED, Goldenberg MN. Democratic and republican physicians provide different care on politicized health issues. Proc Natl Acad Sci USA. 2016;113(42):11811–16. doi:10.1073/pnas.1606609113.
  • Mello MM, Abiola S, Colgrove J. Pharmaceutical companies’ role in state vaccination policymaking: the case of human papillomavirus vaccination. Am J Public Health. 2012;102(5):893–8. doi:10.2105/AJPH.2011.300576.
  • Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009;18(2):363–72. doi:10.1158/1055-9965.EPI-08-0418.
  • Ellis EM, Ferrer RA, Klein WM. Factors beyond lack of knowledge that predict “I don’t know” responses to surveys that assess HPV knowledge. J Health Commun. 2018;23(10–11):967–76. doi:10.1080/10810730.2018.1554729.
  • Cantor D, Coa K, Crystal-Mansour S, Davis T, Dipko S, Sigman R. Health information national trends survey (HINTS) 2007. Rockville (MD): Westat; 2009.
  • Onyeaka HK, Muoghalu C, Deary EC, Ajayi KV, Kyeremeh E, Dosunmu TG, Jawla M, Onaku E, Nwani SP, Asante KO, et al. The role of health information technology in improving awareness of human papillomavirus and human papillomavirus vaccine among US adults. Telemed E-Health. 2022;29:886–95. doi:10.1089/tmj.2022.0381.
  • Chido-Amajuoyi OG, Talluri R, Shete SS, Shete S. Safety concerns or adverse effects as the main reason for human papillomavirus vaccine refusal: national immunization Survey–Teen, 2008 to 2019. JAMA Pediatr. 2021;175(10):1074. doi:10.1001/jamapediatrics.2021.1585.
  • Chido-Amajuoyi OG, Talluri R, Jackson I, Shete SS, Domgue JF, Shete S. The influence of parent–child gender on intentions to refuse HPV vaccination due to safety concerns/side effects, national immunization Survey–Teen, 2010–2019. Hum Vaccin Immunother. 2022;18(5):2086762. doi:10.1080/21645515.2022.2086762.
  • Sharfstein JM, Callaghan T, Carpiano RM, Sgaier SK, Brewer NT, Galvani AP, Lakshmanan R, McFadden SM, Reiss DR, Salmon DA, et al. Uncoupling vaccination from politics: a call to action. Lancet. 2021;398(10307):1211–12. doi:10.1016/S0140-6736(21)02099-7.